Eli Lilly has struck a $2.4 billion deal to buy Dice Therapeutics and its drug discovery and development platform for oral, small molecule therapies for immunological diseases. The big pharma is ...
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Eli Lilly and Company (NYSE:LLY – Get Free Report) last announced its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback